Finally, a recent study in human breast cancer cells has shown that mortalin supports breast cancer stem cells and enhances EMT through activation of the Wnt/GSK3β/β-catenin signaling pathway (Wei et al., 2021). Here, GSK3B is linked to breast cancer.